جست‌وجوی استاد و پژوهشگر

Nagihan Bostanciمشاهده پروفایل

استاد

• Periodontology
• Inflammation Research
• Cell and Molecular Biology
• +۷ مورد دیگر

Prof. Nagihan Bostanci is a Professor of Inflammation Research (Periodontics) and Head of International Affairs at Karolinska Institutet's Department of Dental Medicine. She leads the Master's Degree in Odontology and Oral Health program and holds roles as President of the Microbiology/Immunology Group of the International Association for Dental Research (IADR) and previously served as President of the IADR Periodontal Research Group. Her academic background includes a PhD from the University of London, specialty training at Ege University and UCL, and Habilitation in Oral Biology at the University of Zurich. Research focuses on periodontal homeostasis, inflammatory pathogenesis, and translational approaches for early diagnosis and targeted therapies. Key interests include salivary proteomics, host-microbe interactions, and biomarker discovery. Teaching expertise spans periodontology, diagnostics, and inflammatory pathways at undergraduate and postgraduate levels. She holds certifications in Learning and Teaching (CILT) and is an Associate Fellow of the Higher Education Academy (AFHEA). Major honors include the IADR Sigmund Socransky Young Investigator Award (2014), Philips Oral Healthcare Young Investigator Grant (2009), and Sir Wilfred Fish Prize (2007). Recent grants include Horizon Europe funding for the DELIVER project (€5M) to improve oral care quality and a 2021 award for early tooth loss research. Active in professional leadership, she serves on the editorial board of the Journal of Dental Research and chairs international initiatives in oral microbiology and immunology. Research teams investigate proteome shifts in oral fluids, microbiome dynamics in periodontitis, and clinical applications of biomarkers. Collaborations include studies on peri-implantitis pathogenesis, microbial diagnostics, and the role of intermittent fasting in oral health. Current projects explore aMMP-8 point-of-care testing for disease monitoring and host modulation therapies.

• Alzheimer's Disease
• Neurodegeneration
• Molecular Genetics
• +۳ مورد دیگر

Mikko Hiltunen is a Professor of Tissue and Cell Biology at the Institute of Biomedicine, School of Medicine, University of Eastern Finland. His research focuses on molecular mechanisms of neurodegenerative disorders, particularly Alzheimer's disease and idiopathic normal pressure hydrocephalus (iNPH). He leads several research groups including the Molecular Genetics of Alzheimer's Disease (Hiltunen Lab) and participates in the Brain Research Unit and Genome Center of Eastern Finland. Research interests span Alzheimer's pathogenesis, neuroinflammation, genetic risk factors, biomarker discovery, and therapeutic development. His work integrates molecular biology, genetics, and clinical neuroscience to investigate microglial function, amyloid pathology, and cerebrospinal fluid biomarkers. Key areas include APOE genetics, PLCγ2-mediated neuroprotection, and machine learning applications in neurodegeneration. His recent publications demonstrate a strong focus on cerebrospinal fluid biomarkers, genetic association studies, neuroinflammation mechanisms, and therapeutic interventions. Article themes consistently emphasize microglial biology, genetic risk modifiers, and translational approaches for Alzheimer's and iNPH. Collaborative projects include Neuro-Innovation (2021-2026) and NOVEL MSCA Postdoctoral Programme (2024-2029). Hiltunen leads the Clinical Alzheimer Research group and co-directs the UEF Brain Research Unit. His team utilizes advanced models including iPSC-derived microglia and pericyte systems to study neurovascular interactions. Current work explores phospho-tau immunotherapy, lysosomal dysfunction, and polygenic risk score applications across diverse populations.

• Neuroscience
• Anesthesiology
• Brain Imaging
• +۳ مورد دیگر

Dr. Helene Benveniste is a Professor of Anesthesiology at Yale School of Medicine, specializing in neuroimaging and neurodegenerative diseases. She holds a dual background in Mathematics/Physics (BSc, Katedralskolen) and Medicine (MD and PhD in Neurobiology from University of Copenhagen). Her research focuses on the glymphatic system, cerebrospinal fluid dynamics, and brain waste clearance in aging and neurodegenerative diseases like Alzheimer’s. She has pioneered MRI/PET techniques for studying these processes and contributed to understanding cerebral amyloid angiopathy. Affiliations include the Anesthesiology Department, Yale Biomedical Imaging Institute, and the Center for Brain & Mind Health. Collaborators include Douglas Rothman, D. S. Fahmeed Hyder, and Kevin Behar. Her work spans clinical trials (e.g., SEMALCO trial for alcohol use disorder) and translational research, with over 100 publications. Notable 2025 studies address brain aging, CSF pathways, and glymphatic transport mechanisms. Education: • PhD in Neurobiology, University of Copenhagen (1991) • MD, University of Copenhagen (1986) Research Interests: • Glymphatic system function and dysfunction • Cerebrospinal fluid dynamics in health/disease • Neuroimaging techniques (MRI/PET) • Alzheimer’s and other neurodegenerative diseases • Brain clearance pathways in aging Publications Trends: Recent work emphasizes brain aging, CSF transport, and translational applications like clinical trials for alcohol use disorder. Key themes include glymphatic system dysfunction in neurodegeneration, fluid dynamics modeling, and biomarker discovery. Labs/Teams: Leads a research lab at Yale investigating glymphatic pathways and their role in disease. Collaborates with engineering and mathematics teams to model fluid flows using optimal mass transport algorithms.

Hege Christensenمشاهده پروفایل

استاد

• Pharmacokinetics
• Drug metabolism
• Drug transport
• +۳ مورد دیگر

Hege Christensen is a Professor of Pharmacology at the University of Oslo's Department of Pharmaceutical Biosciences. She has been affiliated with the Department since 1992 and holds leadership roles in academic programs such as the Master's Degree in Pharmacy and Clinical Pharmacy. Her research focuses on pharmacokinetics, particularly drug metabolism variability due to genetic and environmental factors, and drug interactions. She collaborates with institutions like the IMUP Center for Immunopharmacology in Transplantation and the School of Pharmacy at the University of Manchester. Key areas include physiology-based pharmacokinetic modeling and in vitro-in vivo extrapolation techniques. Christensen's education includes a Cand.pharm. from the University of Oslo (1986), a Dr.scient. (1992), and an Advanced Diploma in Clinical Pharmacy Teaching from the University of Leeds (1996). Her career spans roles at the International Heart Research Institute (1991–1992) and pharmaceutical industries like Løvens Kemiske Fabrik (1986–1987). Her research interests emphasize understanding drug bioavailability and optimizing therapies through pharmacokinetic studies. Recent work investigates gastric bypass surgery's effects on drug metabolism and the role of microbiome signatures in weight loss outcomes. She has published extensively in journals like Clinical Pharmacokinetics and Mucosal Immunology, with a focus on cytochrome P450 enzymes, drug transporters, and obesity-related pharmacology. Notable collaborations include projects with Professor Amin Rostami-Hodjegan at the University of Manchester, exploring advanced pharmacokinetic modeling. Her work bridges clinical and translational research, addressing challenges in drug dosing for patients with obesity and comorbidities.

Eugenia Trushinaمشاهده پروفایل

استاد

• Neurodegenerative Diseases
• Mitochondrial Dysfunction
• Alzheimer's Disease
• +۱۳ مورد دیگر

Eugenia Trushina, Ph.D., is a Professor of Neurology and Pharmacology at Mayo Clinic in Rochester, Minnesota, where she serves as a Consultant in the Department of Neurology and the Department of Molecular Pharmacology and Experimental Therapeutics. Her research is centered on mitochondrial dysfunction in neurodegenerative diseases such as Alzheimer's and Huntington's disease, aging, and chemotherapy-induced neuropathy. Ph.D. in Chemistry, Saratov State University Postdoctoral Fellowship, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic Dr. Trushina’s research focuses on the molecular mechanisms of mitochondrial dynamics and function in neurons, particularly how environmental toxins, genetic factors, and chemotherapy drugs contribute to neurodegeneration. Her lab is developing biomarkers for early detection of mitochondrial dysfunction and testing mitochondria-targeted therapeutics to reverse neurodegeneration. Recent work emphasizes mitochondrial complex I inhibition, metabolomics in inclusion body myositis, and neuroprotective small molecules in Alzheimer’s models. Her publication and grant activity show a strong trend in targeting mitochondrial pathways—such as mitophagy, oxidative stress, and metabolic dysregulation—for therapeutic intervention in neurodegenerative and age-related disorders. This includes both preclinical models and translational biomarker development. Dr. Trushina’s research has been funded by: National Institute on Aging (NIA) National Institute of Neurological Disorders and Stroke (NINDS) Mayo Clinic Alzheimer's Disease Research Center Alzheimer Drug Discovery Foundation American Health Assistance Foundation She has served as Principal Investigator (PI) and Co-PI on multiple NIH grants, including ongoing projects on mitochondrial complex I as a neuroprotective target and the role of chronic alcohol exposure in Alzheimer’s pathophysiology. She mentors junior researchers and collaborates across disciplines, though specific student names are not listed. Her work is conducted within the Mitochondrial Neurobiology and Therapeutics research group at Mayo Clinic.

Stephen Chongمشاهده پروفایل

استاد

• Programming Languages
• Information Security
• Language-based Security
• +۳ مورد دیگر

Stephen Chong is a Gordon McKay Professor in the Harvard John A. Paulson School of Engineering and Applied Sciences , where he co-directs the Undergraduate Studies in Computer Science program. His research intersects programming languages and information security , focusing on language-based security frameworks. Education : PhD in Computer Science from Cornell University (2008), B.Sc.(Hons) and B.A. from Victoria University of Wellington (New Zealand). Research : Develops tools like Formulog (Datalog + SMT for static analysis) and Accrue (Java interprocedural analysis), emphasizing security guarantees proportional to programmer effort. Grants : Funded by NSF , DARPA , AFOSR , and Google Faculty Research Award . Recent publications focus on neurosymbolic approaches (e.g., Guess & Sketch ), Datalog synthesis (e.g., Making Formulog Fast ), and quantitative robustness in cyber-physical systems. His group has pioneered formal methods for secure assembly transpilation and sensor attack modeling. Awards : NSF CAREER Award AFOSR Young Investigator Award Sloan Research Fellowship Advising : Supervised numerous PhD and senior thesis students, including Aaron Bembenek , Anitha Gollamudi , and Lucas Waye . Mentored projects like AbcDatalog (multi-threaded Datalog engine) and Shill (secure shell scripting). Labs/Teams : Leads the Programming Languages at Harvard group, collaborating with institutions globally. Organized workshops (e.g., NSF Workshop on Formal Methods for Security ) and chaired committees at conferences like CSF , POPL , and PLDI .

Lisa M. Coussensمشاهده پروفایل

استاد

• Tumor Immunology
• Cancer Microenvironment
• Inflammation in Cancer
• +۳ مورد دیگر

Lisa M. Coussens, PhD, is Chairwoman of the Department of Cell, Developmental & Cancer Biology and Interim Director of the Knight Cancer Institute at Oregon Health & Science University (OHSU), where she holds the Hildegard Lamfrom Endowed Chair in Basic Science. Her research program investigates immune cell functions in solid tumor development, with emphasis on how leukocytes influence cancer progression and therapeutic responses. Using preclinical models of mesothelioma, breast, pancreatic, and head/neck cancers, her lab identifies immunotherapy targets that have advanced to clinical trials for metastatic cancers. Education B.A., San Francisco State University, 1980 Ph.D., University of California, 1993 Postdoctoral Fellowship, University of California San Francisco (Douglas Hanahan Lab) Research Focus Dr. Coussens leads a translational research program examining how immune cells regulate tumor development and therapy responses. Her work integrates molecular oncology, immunology, and preclinical modeling to identify: 1) Immune pathways co-opted by developing tumors, 2) Mechanisms of leukocyte-mediated therapy resistance, and 3) Biomarkers for immunotherapy response. Current work emphasizes spatial analysis of tumor-immune interactions using multiplexed imaging and computational approaches. Her recent publications reflect strong emphasis on tumor microenvironment dynamics, immunotherapy mechanisms, and translational applications in pancreatic, breast, and head/neck cancers. Studies frequently incorporate spatial biology techniques, clinical correlation analyses, and novel therapeutic combinations targeting immune pathways. Honors & Awards National Academy of Sciences Member (2023) National Academy of Medicine Member (2024) AACR President (2022-2023) Susan G. Komen Brinker Award (2018) Fellow of AACR Academy (2019) Fellow of AAAS (2018) Rosalind E. Franklin Award, NCI (2015) Honorary Doctorate, University of Buenos Aires (2018) Princess Takamatsu Memorial Lectureship (2018) European Academy of Tumor Immunology Career Award (2018) Gertrude B. Elion Award (2001) Charlotte Friend Lectureship (2012) Margaret L. Kripke Legend Award (2023) Johns Hopkins Heroine of Public Health (2024) Fellow of Academy of ImmunoOncology (2022) Dr. Coussens directs translational research programs at OHSU's Knight Cancer Institute and leads multidisciplinary collaborations investigating tumor-immune crosstalk. Her laboratory develops innovative preclinical platforms for evaluating combination immunotherapies.

• Veterinary Medicine
• Dairy Cattle Health
• Reproductive Health
• +۴ مورد دیگر

Prof. Jocelyn Dubuc is a Full Professor at the Faculty of Veterinary Medicine (Université de Montréal), specializing in bovine population health and reproductive medicine. He leads the Department of Clinical Sciences , focusing on dairy cow uterine health, metabolic diseases, and epidemiology. His work bridges clinical practice and research, emphasizing evidence-based management strategies. Education: 2005: DVM, Université de Montréal 2007: MSc in Veterinary Sciences, Université de Montréal 2010: PhD in Veterinary Science, University of Guelph Research Focus: Uterine infections and postpartum disorders Metabolic diseases (e.g., ketosis) Antimicrobial stewardship On-farm diagnostic tools Reproductive tract disease epidemiology His studies have redefined understanding of postpartum endometritis and shaped clinical guidelines for dairy herd management. Awards: 2013: Prix Carl J. Norden for Teaching Excellence 2015: Journal of Dairy Science Loyalty Program Grants & Collaborations: Leading projects funded by MAPAQ, FRQNT, and industry partnerships. Key member of RQR (Reproduction Network) and Op+lait (Dairy Quality Optimization). Developed courses on uterine health monitoring and metabolic diagnostics. Teams: Collaborates with over 100 researchers in networks like Vetmétabo (AI-driven veterinary medicine) and the Québec Dairy Health Benchmarking Initiative.

Soh Youn Suhمشاهده پروفایل

استادیار

• Pediatric Ophthalmology
• Strabismus
• Neuro-Ophthalmology
• +۳ مورد دیگر

Dr. Soh Youn Suh serves as an Assistant Professor of Ophthalmology at UCLA's Stein Eye Institute within the David Geffen School of Medicine, specializing in pediatric ophthalmology and adult strabismus care at the Los Angeles clinical site. Her clinical expertise addresses complex eye alignment disorders and childhood vision conditions. Education: MD, Ewha Womans University School of Medicine, 2006 MS, Ewha Woman's University, 2010 Ophthalmology Residency, Ewha Womans University Medical Center, 2011 Pediatric Ophthalmology & Neuro-Ophthalmology Fellowship, Seoul National University Hospital, 2013 Pediatric Ophthalmology & Adult Strabismus Fellowship, Stein Eye Institute, UCLA, 2014 Research Fellowship, Ocular Motility Laboratory, Stein Eye Institute, UCLA, 2018 Her research program investigates biomechanical interactions between extraocular muscles, optic nerves, and orbital structures using advanced MRI and OCT imaging. Key discoveries include documenting abnormal optic nerve traction during eye movements in glaucoma patients with normal intraocular pressure and characterizing muscle pulley displacements in strabismus conditions. This work bridges neuro-ophthalmology and surgical planning through quantitative orbital analysis. Analysis of her 15 most recent publications (2020-2025) reveals three dominant research trajectories: (1) AI-driven segmentation of orbital structures using deep learning, (2) cerebrospinal fluid dynamics in optic neuropathies, and (3) biomechanical modeling of optic nerve strain during horizontal eye movements. These studies increasingly integrate computational methods with high-resolution imaging to decode pathophysiological mechanisms in strabismus and glaucoma. Scientific Recognition: Excellence in Research Award, Stein Eye Institute (2015) Excellence in Research Award, Stein Eye Institute (2016) Excellence in Research Award, Stein Eye Institute (2018) Dr. Suh has developed collaborative research partnerships through UCLA's institutional resources, particularly within Dr. Joseph L. Demer's ocular motility laboratory where she conducted postdoctoral research. Her work receives consistent institutional support through Stein Eye Institute infrastructure, though specific external grant funding isn't documented in source materials. She actively contributes to training through co-authorship with junior researchers on technical imaging studies. Her current research team at the Stein Eye Institute operates an orbital biomechanics laboratory focused on translating MRI/OCT findings into clinical applications. The group specializes in computational modeling of eye movement dynamics and developing AI tools for surgical planning in complex strabismus cases, with ongoing projects examining cerebrospinal fluid interactions in optic nerve disorders.

Geir Andre Ringstadمشاهده پروفایل

دانشیار

• Neuroimaging
• Cerebrospinal Fluid Dynamics
• Glymphatic System
• +۳ مورد دیگر

Geir Andre Ringstad is an Associate Professor at the Department of Radiology and Nuclear Medicine , University of Oslo, specializing in neuroimaging and cerebrospinal fluid (CSF) dynamics . His research focuses on the glymphatic system , CSF tracer studies , and MRI-based quantification of brain clearance mechanisms. Research Themes Neurofluid dynamics and glymphatic dysfunction in normal pressure hydrocephalus , Chiari malformation , and pineal cysts Impact of sleep deprivation on CSF tracer clearance Novel MRI protocols for assessing CSF disorders and neuroimmune interfaces Publications cover diverse topics including glymphatic-lymphatic coupling , CSF flow modeling , contrast agent safety , and computational analysis of neurofluid pathways. Collaborative work spans neurosurgery , endocrinology , and biophysics .

• Traumatic Brain Injury
• Neurosurgery
• Intensive Care Medicine
• +۳ مورد دیگر

Elham Rostami is an Associate Professor of Neurosurgery and Researcher at Karolinska Institutet's Department of Neuroscience, specializing in traumatic brain injury (TBI) pathophysiology and outcome prediction. She chairs the young committee of the European Association of Neurosurgical Societies (EANS) trauma section since 2017 and leads research in the Experimental Traumatology Research Unit. Her educational background includes: Medical Degree, Karolinska Institutet, 2008 PhD in Neuroscience, Karolinska Institutet, 2012 Dr. Rostami's research focuses on multimodal TBI monitoring using cerebral microdialysis to analyze energy metabolism and blood flow dynamics, combined with genetic analysis and patient-specific iPSC models. Her work aims to identify prognostic markers explaining differential recovery patterns and the role of genetic background in TBI outcomes, bridging clinical neurosurgery with molecular neuroscience. Analysis of her 15 most recent publications reveals strong thematic continuity in neurocritical care monitoring techniques, with significant expansion into neurological complications of infectious diseases (particularly COVID-19) since 2020. Her work consistently emphasizes translational applications of cerebral blood flow monitoring, biomarker validation, and genetic factors in neurotrauma, often involving large-scale clinical collaborations across European institutions. Dr. Rostami has not listed any specific scientific awards in her institutional profile. While her profile indicates active research leadership and committee chairmanship, specific details about grant funding or student advising are not provided in available materials. She operates within Karolinska Institutet's Experimental Traumatology Research Unit, where her team integrates clinical neurosurgical practice with preclinical TBI modeling, microdialysis data analysis, and genetic investigation to develop personalized TBI management approaches.

Alan Huntمشاهده پروفایل

عضو هیئت علمی

• Lipid Biochemistry
• Metabolism
• Coral Reef Biochemistry
• +۴ مورد دیگر

Alan Hunt is a Senior Teaching Fellow in the Faculty of Medicine at the University of Southampton. He holds a BSc in Physiology & Biochemistry (1979) and a PhD in lipid biochemistry (1987) from the same institution. His research focuses on lipid metabolism, coral reef biochemistry under climate change, and biomedical applications. He has established international collaborations in lipid metabolism and coral reef studies. Teaching roles include Deputy Year 2 Lead for BM5/BM6/BMEU programs and expertise in physiology, biochemistry, and research methodologies. He received the Vice-Chancellor's Teaching Award in 2005 for interprofessional learning innovations. Education: BSc Physiology & Biochemistry, University of Southampton, 1979 PhD in lipid biochemistry (part-time), University of Southampton, 1987 Research Interests: Lipid biochemistry, coral reef symbiont stress tolerance, pulmonary surfactant metabolism, and interdisciplinary biomedical research. Notable projects include studying heat tolerance in Persian Gulf corals and lipid dynamics in pulmonary diseases. Awards: 2005 Vice-Chancellor's Teaching Award (Medical Faculty) Teaching & Advising: 30+ years of teaching in medical and biomedical programs, including leadership roles in curriculum design (e.g., 'Research for Medicine & Health' module). Active in interprofessional education and critical appraisal training. No named advisees listed.

Sung Kimمشاهده پروفایل

دانشیار

• Epigenetic regulation of immune responses
• Macrophage biology
• Innate immunity
• +۳ مورد دیگر

Sung Kim is an Associate Professor at The University of Western Ontario, where he leads the Kim Lab (http://www.kimlab-uwo.com/). He holds a PhD from the University of British Columbia and completed his postdoctoral training at The Scripps Research Institute in San Diego. His research focuses on understanding epigenetic and signaling mechanisms governing macrophage responses to microbes, tissue injury, and cancer. His work investigates how macrophages adapt to environmental cues through epigenetic reprogramming, particularly in contexts of immune tolerance (e.g., to commensal bacteria) and immune dysregulation (e.g., in tumors). Key areas include histone acetylation-mediated tolerance to bacterial components like lipopolysaccharides, and transcription factor roles in tumor-associated macrophage behavior. Publications highlight contributions to understanding anthrax toxin pathogenesis, probiotic immunomodulation (via Lactobacillus rhamnosus), and mechanisms of cytokine regulation (e.g., IL-1β, G-CSF). His lab employs genetic, biochemical, and cellular approaches to dissect signaling pathways in macrophage plasticity. Notable research tools include quasi-haploid RAW 264.7 cell mutagenesis systems and in vivo models of colitis and probiotic efficacy. Current projects aim to translate epigenetic insights into therapeutic strategies for inflammatory diseases and cancer immunotherapy.

Tao Xingمشاهده پروفایل

استاد

• Computational Fluid Dynamics (CFD)
• Verification and Validation (V&V)
• Fluid-Structure Interactions
• +۵ مورد دیگر

Dr. Tao Xing is a Professor in the Department of Mechanical Engineering at the University of Idaho. He holds a Ph.D. in Mechanical Engineering from Purdue University (2002) and is a licensed Professional Engineer (P.E.). His research focuses on computational fluid dynamics (CFD), verification/validation (V&V), biofluids, and wind turbine design. He directs the 3D Imaging and Printing Laboratory and has secured $3.8M+ in research funding from NSF, NIH, and industry. Key awards include the 2019 University Excellence in Interdisciplinary Collaboration Award and 2018 Mid-Career Faculty Award. His educational contributions include developing adaptive learning modules for ABET outcomes and integrating CFD into engineering curricula. He has advised 6 graduate students and currently mentors 2 Ph.D. candidates. Notable projects include aerogel insulation systems, CSF drug delivery modeling, and offshore wind turbine simulations.

Andrew Conway Morrisمشاهده پروفایل

پژوهشگر

• Neutrophil Biology
• Host-Microbe Interactions
• Critical Illness
• +۴ مورد دیگر

Dr. Andrew Conway Morris is a Researcher at the Department of Pathology , University of Cambridge. He serves as an Honorary Consultant in Intensive Care Medicine at Addenbrooke's Hospital and leads the Conway Group focusing on immune dysfunction in critical illness. Role : MRC Clinician Scientist Location : Laboratory Block, Addenbrooke's Hospital, Cambridge Biomedical Campus Research Interests include: Neutrophil biology and phagosomal maturation Host-microbe interactions in pneumonia and sepsis Immune dysfunction in critical illness via C5a and PI3Kδ pathways Molecular diagnostics for infections Translational immunology to clinical trials (e.g., GM-CSF therapy) Scientific Output spans 2025-2020 publications on topics like: Subphenotyping severe infections Immune modulation in respiratory failure Metabolic and phosphoproteomic profiling Antibiotic stewardship and ICU sustainability Awards : MRC Clinician Scientist Fellowship Education & Training : As an MRC-funded clinician scientist, he bridges clinical practice (intensive care) with fundamental research on immune cell signaling. Collaborations : Works with Professor Klaus Okkenhaug (Immunology), Dr. Betty Chung (Microbiology), and global critical care networks.